Chad Cowan - 20 Nov 2025 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role: Chief Scientific Officer
Signature: /s/ Douglas Carr, Attorney-in-Fact
Issuer symbol: IPSC
Transactions as of: 20 Nov 2025
Net transactions value: -$2,736
Form type: 4
Filing time: 24 Nov 2025, 16:05:55 UTC
Previous filing: 22 Sep 2025
Next filing: 29 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cowan Chad	Chief Scientific Officer	C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA	/s/ Douglas Carr, Attorney-in-Fact	24 Nov 2025	0002039294

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IPSC	Common Stock	Sale	$2,736	-5,462	-0.55%	$0.5010	987,027	20 Nov 2025	Direct	F1
holding	IPSC	Common Stock						10,697	20 Nov 2025	By Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
F2	Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.